Harmand T, Islam A, Pishesha N, Ploegh H
RSC Chem Biol. 2021; 2(3):685-701.
PMID: 34212147
PMC: 8190910.
DOI: 10.1039/d1cb00023c.
Klingler M, Hormann A, von Guggenberg E
Curr Med Chem. 2020; 27(41):7112-7132.
PMID: 32586246
PMC: 7116483.
DOI: 10.2174/0929867327666200625143035.
Giganti F, Tang L, Baba H
Eur Radiol. 2018; 29(4):1743-1753.
PMID: 30280246
PMC: 6420485.
DOI: 10.1007/s00330-018-5732-4.
Wang X, Feng H, Zhao S, Xu J, Wu X, Cui J
Oncotarget. 2017; 8(12):20476-20495.
PMID: 28108738
PMC: 5386778.
DOI: 10.18632/oncotarget.14730.
Zayed A, Mandrekar S, Haluska P
Chin Clin Oncol. 2015; 4(3):30.
PMID: 26408297
PMC: 4750944.
DOI: 10.3978/j.issn.2304-3865.2015.04.01.
PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases.
Lu F, Yuan Z
Quant Imaging Med Surg. 2015; 5(3):433-47.
PMID: 26029646
PMC: 4426104.
DOI: 10.3978/j.issn.2223-4292.2015.03.16.
Targeting the de novo biosynthesis of thymidylate for the development of a PET probe for pancreatic cancer imaging.
Nilaweera T, Saeed M, Kohen A
Biochemistry. 2015; 54(5):1287-93.
PMID: 25581782
PMC: 4324125.
DOI: 10.1021/bi501481n.
Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review).
Liu S, Xu X, Zeng X, Li L, Chen Q, Li J
Oncol Lett. 2014; 8(6):2359-2366.
PMID: 25364397
PMC: 4214492.
DOI: 10.3892/ol.2014.2525.
Patient-derived xenograft models: an emerging platform for translational cancer research.
Hidalgo M, Amant F, Biankin A, Budinska E, Byrne A, Caldas C
Cancer Discov. 2014; 4(9):998-1013.
PMID: 25185190
PMC: 4167608.
DOI: 10.1158/2159-8290.CD-14-0001.
Nanobody: the "magic bullet" for molecular imaging?.
Chakravarty R, Goel S, Cai W
Theranostics. 2014; 4(4):386-98.
PMID: 24578722
PMC: 3936291.
DOI: 10.7150/thno.8006.
Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation.
Cyran C, Kazmierczak P, Hirner H, Moser M, Ingrisch M, Havla L
PLoS One. 2013; 8(9):e76009.
PMID: 24098755
PMC: 3786893.
DOI: 10.1371/journal.pone.0076009.
Has discovery-based cancer research been a bust?.
Epstein R
Clin Transl Oncol. 2013; 15(11):865-70.
PMID: 24002944
DOI: 10.1007/s12094-013-1071-8.
Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
Dangaj D, Lanitis E, Zhao A, Joshi S, Cheng Y, Sandaltzopoulos R
Cancer Res. 2013; 73(15):4820-9.
PMID: 23722540
PMC: 3732560.
DOI: 10.1158/0008-5472.CAN-12-3457.
Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.
Xiao L, Zhang Y, Yue W, Xie X, Wang J, Chordia M
Nucl Med Biol. 2013; 40(3):351-60.
PMID: 23375364
PMC: 3643142.
DOI: 10.1016/j.nucmedbio.2013.01.001.
Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice.
Zagozdzon A, OLeary P, Callanan J, Crown J, Gallagher W, Zagozdzon R
BMC Cancer. 2012; 12:209.
PMID: 22646761
PMC: 3411433.
DOI: 10.1186/1471-2407-12-209.
Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.
Bunschoten A, Buckle T, Visser N, Kuil J, Yuan H, Josephson L
Chembiochem. 2012; 13(7):1039-45.
PMID: 22505018
PMC: 3498954.
DOI: 10.1002/cbic.201200034.
Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration.
Zhou J, Ju W, Wang D, Wu L, Zhu X, Guo Z
PLoS One. 2012; 7(4):e33577.
PMID: 22496754
PMC: 3319545.
DOI: 10.1371/journal.pone.0033577.
Novel positron emission tomography tracer distinguishes normal from cancerous cells.
Saeed M, Sheff D, Kohen A
J Biol Chem. 2011; 286(39):33872-8.
PMID: 21832075
PMC: 3190779.
DOI: 10.1074/jbc.M111.275446.
99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation.
Pesnel S, Guminski Y, Pillon A, Lerondel S, Imbert T, Guilbaud N
Eur J Nucl Med Mol Imaging. 2011; 38(10):1832-41.
PMID: 21660624
DOI: 10.1007/s00259-011-1857-2.